Healthcare.gov 3.0 — Behavioral Economics and Insurance Exchanges
“Healthcare.gov 3.0 — Behavioral Economics and Insurance Exchanges” – The New England Journal of Medicine
“Healthcare.gov 3.0 — Behavioral Economics and Insurance Exchanges” – The New England Journal of Medicine
Surgery can be risky. People with major cardiovascular or respiratory illnesses undergoing major surgeries, for example, are at risk for major surgical complications, even death. But healthy people receiving less intense interventions typically fly through with nary a concern. Nevertheless, perhaps worried about those few patients who suffer major complications, many physicians order a gaggle…
It used to be that hospitals billed Medicare for the services they provided, and Medicare – I know this is crazy! – simply paid the bills. Those days are rapidly receding into history. Soon, a significant chunk of hospital revenue will be at risk, under a series of Medicare pay-for-performance programs. The idea behind P4P…
Shutterstock When it comes to wreaking havoc on people’s bodies, diabetes isn’t picky, wreaking havoc upon people’s hearts, brains, eyes, kidneys, and peripheral nerves. To forestall such damage, many people with diabetes withstand another kind of bodily harm—they prick blood from their fingers each day to test their blood sugar. For many people with Type…
Even before Obamacare became the law of the land, the U.S. health care system was undergoing a dramatic transformation. Millions of people were shifting from generous health insurance plans to consumer-directed ones that pair low monthly premiums with high out-of-pocket costs. This shift has been encouraged by employers, eager to reduce the cost of employee…
I have written about medical marijuana before, relaying research findings showing that the legalization of medical marijuana is associated with a reduction in use of pain medications. Here’s another piece of evidence leading to a similar conclusion, from a study by the research team of Bradford and Bradford out of the University of Georgia. (Athens,…
Peter Bach and I have an essay in the Annals of Internal Medicine laying out some of the problems with pharmaceutical funded copay assistance programs. Check it out.